Topics In Demand
Notification
New

No notification found.

Digital Health Trends triggered by COVID-19
Digital Health Trends triggered by COVID-19

745

0

COVID-19 is incontestably the greatest challenge healthcare organizations across the globe have faced in recent history. Resources have been redeployed systemwide to respond to the pandemic, while a backlog for non-COVID-19 care continues to grow steadily.

COVID-19 is acting as a transformation catalyst, accelerating the implementation and adoption of the change in healthcare delivery at an unprecedented scale. New models of care, using remote healthcare solutions and digital technologies, are emerging across the care continuum and are likely to remain in place after the crisis phase has passed. 

Virtual patient consultations are now widespread 

The scope of video consultation is wide, particularly for the management of long-term conditions, including diabetes, hypertension, asthma, stroke, psychiatric illnesses, cancers, and chronic pain. Virtual consultations reduce patient flow through healthcare facilities and limit infectious exposures, but more importantly, they facilitate and broaden access to healthcare. There is unlikely to be a return to pre-pandemic levels of in-person patient consultations. 

Digital monitoring solutions and self-care will continue to increase

Patient self-monitoring in the home setting has been accelerated to promote distancing and to release resources for COVID-19 care. Looking beyond the crisis, these solutions offer a range of benefits, especially to those living with long-term conditions. Wearables, such as heart rate sensors, exercise trackers, sweat meters, and oximeters, provide real-time information to patients, enabling self-care. Patients are engaged and empowered to manage their own care; it reduces the need to visit bricks and mortar clinical settings, cases can be triaged, resources are directed where the need is greatest and clinician work experience is improved. Moreover, increased self-management of long-term chronic conditions has the potential to have a significant impact on health budgets. 

Connected Devices and the IoMT will enable the transformation of care delivery at disease-level

The IoMT goes beyond patient self-monitoring. It is a connected infrastructure of medical devices, software applications, and health systems and services. This facilitates personalized treatments at scale and embraces the end-to-end patient journey, extending beyond episodes of care. Several factors are driving the expansion of this market; the evolution of high-speed networking technologies, the increasing penetration of smartphones, tablets, and other mobile platforms and, most importantly, patients’ acceptance of remote care and their increased use of connected medical devices. It is expected that there will be further integration of medical devices, patient records, health systems and platforms to deliver the anticipated benefits and outcomes. Medtech innovators are responding in two key ways. Firstly, they seek to understand the impact their device will have across the care pathway and so have started to formulate propositions that go beyond product features and benefits. Secondly, they recognize that these connected devices are in the hands of patients and are increasingly incorporating consumer design principles into the development of their products from the outset, focusing on convenience, experience, and personalization. 

Diagnostics will continue to play an integral role in healthcare

For many years, diagnostics has been in the shadow of treatment. In 2020, because of COVID-19, diagnostics took centre stage. Accurate detection and timely interventions, such as self-isolation, emerged as a pressing need. Diagnostics has the power to deliver far beyond the current pandemic; they play a vital role in screening, preventing and monitoring disease, as well as informing prognosis, enabling targeted treatments and determining outcomes. Diagnostics will continue to play a pivotal role in disease management beyond COVID-19 and the market is expected to grow significantly. Market And Markets forecast that the IVD market alone will grow to $96 billion by 2025. COVID-19 has demonstrated the demand for low-cost, point-of-care, consumer-friendly diagnostic tests, where there is expected to be an increased focus on innovation in 2021 and beyond. 

Looking beyond 2021 

COVID-19 has demonstrated how healthcare systems can rapidly deploy new technologies and care models, with internet-first and home services at scale at the forefront. It’s clear there can be no return to the previous status quo. This system-wide desire for change represents an opportunity for MedTech innovators to expand innovative solutions beyond acute hospital settings, into broader care settings, and across the entire care pathway. 

 

Source/References: Med Tech News


That the contents of third-party articles/blogs published here on the website, and the interpretation of all information in the article/blogs such as data, maps, numbers, opinions etc. displayed in the article/blogs and views or the opinions expressed within the content are solely of the author's; and do not reflect the opinions and beliefs of NASSCOM or its affiliates in any manner. NASSCOM does not take any liability w.r.t. content in any manner and will not be liable in any manner whatsoever for any kind of liability arising out of any act, error or omission. The contents of third-party article/blogs published, are provided solely as convenience; and the presence of these articles/blogs should not, under any circumstances, be considered as an endorsement of the contents by NASSCOM in any manner; and if you chose to access these articles/blogs , you do so at your own risk.


images
Nishant Kumar
Technology Enthusiast

© Copyright nasscom. All Rights Reserved.